Pieris Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 -100.0% -€14.93M -29.0% N/A -€9.28M -79.8% N/A
    €36.65M +65.3% -€21.01M -21.5% -57.3% +0.63 pp -€45.93M -8.9% -125.3% +1.0 pp
    €22.17M -17.6% -€26.76M -27.9% -120.7% +0.17 pp -€50.42M +777.5% -227.4% -2.1 pp
    €26.90M +7.1% -€37.13M +16.5% -138.0% -0.11 pp -€5.75M -84.5% -21.4% +1.3 pp
    €25.10M -36.6% -€31.87M +56.7% -127.0% -0.76 pp -€36.96M -13.7% -147.2% -0.39 pp
    €39.62M +59.0% -€20.34M -11.2% -51.3% +0.41 pp -€42.81M -8,012.2% -108.1% -1.1 pp
    €24.91M +15.1% -€22.90M +51.6% -91.9% -0.22 pp €541.05K -98.8% 2.2% -2.0 pp
    €21.64M +333.5% -€15.11M -22.6% -69.8% +3.2 pp €44.26M -474.5% 204.6% +4.4 pp
    €4.99M +98.9% -€19.52M +62.2% -391.0% +0.88 pp -€11.82M +14.3% -236.8% +1.8 pp
    €2.51M -45.4% -€12.04M +42.7% -479.5% -3.0 pp -€10.35M +151.9% -412.2% -3.2 pp
    €4.59M -45.7% -€8.43M -14,980.0% -183.6% -1.8 pp -€4.11M +58.5% -89.4% -0.59 pp
    €8.46M -13.2% €56.67K -102.9% 0.7% +0.21 pp -€2.59M -66.2% -30.6% +0.48 pp
    €9.75M -€1.99M -20.4% -€7.67M -78.7%

    Notifications